AboutSign In

OPTIMA Trial

Event

Phase III clinical trial testing Prosigna-guided chemotherapy decisions in HR+/HER2- breast cancer

1 story

01
health4h ago

New Genomic Test Could Eliminate Need for Chemotherapy in Millions of Breast Cancer Patients

11 min read